Kedrion
Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
DitchCarbon Score
How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kedrion's score of 33 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Kedrion's reported carbon emissions
In 2023, Kedrion reported total carbon emissions of approximately 60,821 kg CO2e, comprising about 27,304 kg CO2e from Scope 1 emissions and about 33,517 kg CO2e from Scope 2 emissions. This reflects a continued commitment to monitoring and managing their carbon footprint, although specific reduction targets or initiatives have not been disclosed. In previous years, Kedrion's emissions have varied significantly. For instance, in 2022, the company recorded approximately 66,104 kg CO2e, with Scope 1 emissions at about 30,122 kg CO2e and Scope 2 emissions at about 35,982 kg CO2e. The trend shows a general decrease in emissions from 2016, when total emissions were about 50,000 kg CO2e, indicating a potential focus on sustainability. Kedrion has not publicly committed to specific science-based targets or reduction initiatives, which places them in a broader industry context where many companies are increasingly setting ambitious climate goals. The absence of defined reduction targets suggests an opportunity for Kedrion to enhance its climate strategy and align with global sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 32,365,000 | 00,000,000 | 00,000,000 | 0,000 | 00,000,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 18,358,000 | 00,000,000 | 00,000,000 | 00 | 00 | 00,000 | 00,000 | 00,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kedrion is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
